Uploaded June 2026 | Updated September 2026, 2 weeks ago
Can a passive magnetic scan see what an EKG might miss? In this fireside chat, Kit Yee Au-Yeung (General Manager of AQMed at SandboxAQ) sits down with Dr. Mohamad Alkhouli, Interventional Cardiologist and Vice Chair for Strategic Partnerships at the Mayo Clinic, to discuss the revolutionary potential of Magnetocardiography (MCG).
Discover how AI and sensor technology converge to unlock MCG, potentially aiding in the diagnosis of high-risk coronary artery disease and potentially addressing gaps where conventional diagnostics may fall short.
Key topics you'll hear about:
-Why MCG could provide a richer, purer signal than traditional electrocardiograms (EKG/ECG).
-How modern sensors eliminated the need for expensive liquid helium "squid" cooling systems.
-Using machine learning and AI to analyze complex spatiotemporal heart signals.
-Exploring non-invasive heart rhythm mapping and point-of-care cardiac tracking.
đź’ˇ ABOUT THE SPEAKERS
-Dr. Mohamad Alkhouli is a practicing interventional cardiologist, Vice Chair for Strategic Partnerships in the Cardiovascular Medicine Department at the Mayo Clinic, and Chair of the Scientific Advisory Board for AQMed.
-Kit Yee Au-Yeung is the General Manager of AQMed at SandboxAQ and a former Product Manager at Google X.
Note: AQMed’s Magnetocardiography (MCG) technology is currently investigational and is not yet FDA-cleared or approved for commercial use.
👉 Learn more about SandboxAQ & AQMed here: sandboxaq.com/solutions/aqmed
👉 Subscribe for more exclusive interviews on deep tech innovations
Chapters:
00:00 - Introduction & Meet Dr. Mohamad Alkhouli (Mayo Clinic)
01:14 - What is Magnetocardiography (MCG)?
01:39 - Technology in Search of a Problem: The Nitinol Analogy
03:39 - Why Now? Overcoming the Historical Barriers of MCG
04:56 - The Convergence of Advanced Sensors and AI Power
06:17 - Potential Clinical Applications for MCG: Ischemia, Cardiomyopathy, and Arrhythmia
07:39 - Addressing the Under- and Over-Diagnosis Problem of EKGs
11:04 - Real-World Research Findings (Takotsubo & Amyloidosis)
12:54 - The Advantages of MCG’s Passive Sensor Technology
13:48 - Unlocking MCG’s Full Potential: A Call to Clinical Champions
#sandboxaq #aqmed #cardiology #healthtech #aiinmedicine #mayoclinic #medtech #hearthealth #biomedicalengineering
Can a passive magnetic scan see what an EKG might miss? In this fireside chat, Kit Yee Au-Yeung (General Manager of AQMed at SandboxAQ) sits down with Dr. Mohamad Alkhouli, Interventional Cardiologist and Vice Chair for Strategic Partnerships at the Mayo Clinic, to discuss the revolutionary potential of Magnetocardiography (MCG).
Discover how AI and sensor technology converge to unlock MCG, potentially aiding in the diagnosis of high-risk coronary artery disease and potentially addressing gaps where conventional diagnostics may fall short.
Key topics you'll hear about:
-Why MCG could provide a richer, purer signal than traditional electrocardiograms (EKG/ECG).
-How modern sensors eliminated the need for expensive liquid helium "squid" cooling systems.
-Using machine learning and AI to analyze complex spatiotemporal heart signals.
-Exploring non-invasive heart rhythm mapping and point-of-care cardiac tracking.
đź’ˇ ABOUT THE SPEAKERS
-Dr. Mohamad Alkhouli is a practicing interventional cardiologist, Vice Chair for Strategic Partnerships in the Cardiovascular Medicine Department at the Mayo Clinic, and Chair of the Scientific Advisory Board for AQMed.
-Kit Yee Au-Yeung is the General Manager of AQMed at SandboxAQ and a former Product Manager at Google X.
Note: AQMed’s Magnetocardiography (MCG) technology is currently investigational and is not yet FDA-cleared or approved for commercial use.
👉 Learn more about SandboxAQ & AQMed here: sandboxaq.com/solutions/aqmed
👉 Subscribe for more exclusive interviews on deep tech innovations
Chapters:
00:00 - Introduction & Meet Dr. Mohamad Alkhouli (Mayo Clinic)
01:14 - What is Magnetocardiography (MCG)?
01:39 - Technology in Search of a Problem: The Nitinol Analogy
03:39 - Why Now? Overcoming the Historical Barriers of MCG
04:56 - The Convergence of Advanced Sensors and AI Power
06:17 - Potential Clinical Applications for MCG: Ischemia, Cardiomyopathy, and Arrhythmia
07:39 - Addressing the Under- and Over-Diagnosis Problem of EKGs
11:04 - Real-World Research Findings (Takotsubo & Amyloidosis)
12:54 - The Advantages of MCG’s Passive Sensor Technology
13:48 - Unlocking MCG’s Full Potential: A Call to Clinical Champions
#sandboxaq #aqmed #cardiology #healthtech #aiinmedicine #mayoclinic #medtech #hearthealth #biomedicalengineering
